GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] "EU rules" is almost always a national question wearing a European hat — 22 comments in the full submission. View in context.
375
c/glp1eu·submitted 17 days ago by u/fabio_nkemelu

[Discussion] "EU rules" is almost always a national question wearing a European hat

Discussionbranch of 7 comments

"EU rules" is almost always a national question wearing a European hat. I have gone back and forth on this for months. The structure that makes this board make sense, once. Marketing authorisation for these products is granted centrally, which is why the same product exists across the union. Everything after that —…

Read the full submission and all 22 comments →

This branch

7 comments, started 15 days ago
u/solene_ilunga5 points·15 days ago

Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.

replysharereportpermalink
u/dario_stanescu3 points·15 days ago

Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.

Adding the practical step — read your own country’s published criteria. They exist and they are definitive.

replysharereportpermalink
u/joaquin_trevino1 point·15 days ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink
u/tuva_aalto1 point·15 days ago

a shortage in one member state is not a shortage in all of them

Disagreeing with this bit: that criterion belongs to one member state and is being quoted as general.

replysharereportpermalink
u/enzo_petrescu1 point·14 days ago

Agreed that pharmacy margin regulation explains a lot of the price differences people find mysterious.

replysharereportpermalink
load more comments (2) →

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.